|Bid||45.80 x 1000|
|Ask||46.70 x 800|
|Day's range||43.68 - 45.27|
|52-week range||24.16 - 59.15|
|Beta (5Y monthly)||0.71|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||37.77|
Regulatory and pipeline updates from bigwigs like Regeneron (REGN) and Biogen (BIIB) have been the biotech sector's few key highlights during the past week.
Valneva's (VALN) shares surge after its COVID vaccine demonstrates superiority over AstraZeneca's COVID vaccine in a phase III study.
These COVID-19 vaccine developers are all moving in response to strong late-stage results for Valneva's VLA2001.